Therapy of Autoimmune Diseases with Antibody to Immune Response Gene Products or to T‐Cell Surface Markers^a

This publication has 14 references indexed in Scilit:

• Successful treatment of autoimmunity in NZB/NZW F1 mice with monoclonal antibody to L3T4.
  The Journal of Experimental Medicine, 1985
• Reversal of Experimental Allergic Encephalomyelitis with Monoclonal Antibody to a T-Cell Subset Marker
  Science, 1985
• Chimeric human antibody molecules: mouse antigen-binding domains with human constant region domains.
  Proceedings of the National Academy of Sciences, 1984
• Disappearance and reappearance of B cells after in vivo treatment with monoclonal anti-I-A antibodies.
  Proceedings of the National Academy of Sciences, 1984
• Anti I-A antibody suppresses active encephalomyelitis: treatment model for diseases linked to IR genes.
  The Journal of Experimental Medicine, 1983
• Treatment of (NZB x NZW)F1 disease with anti-I-A monoclonal antibodies.
  The Journal of Experimental Medicine, 1983
• Prevention of experimental allergic encephalitis with in vivo administration of anti I-A antibody☆Decreased accumulation of radiolabelled lymph node cells in the central nervous system
  Journal of Neuroimmunology, 1983
• In vivo therapy with monoclonal anti-I-A antibody suppresses immune responses to acetylcholine receptor
  Proceedings of the National Academy of Sciences, 1983
• Conversion of immunity to suppression by in vivo administration of I-A subregion-specific antibodies.
  The Journal of Experimental Medicine, 1982
• In vivo effects of antibodies to immune response gene products. I. Haplotype-specific suppression of humoral immune responses with a monoclonal anti-I-A.
  The Journal of Experimental Medicine, 1981